PharmaShots | Incisive News in 3 Shots

Subscribe Now

Advanced or Metastatic Non-Small Cell Lung Cancer

Amgen's Sotorasib Receives the US FDA's Breakthrough Therapy Designation for Advanced or Metastatic NSCLC with KRAS G12C Mutation

Amgen's Sotorasib Receives the US FDA's Breakthrough Therapy Designation for Advanced or Metastatic NSCLC with KRAS G12C Mutation

December 9, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us